Real-world Outcomes Among Patients With Melanoma Treated With Neoadjuvant Nivolumab+Relatlimab or Nivolumab+Ipilimumab
Clinical trial NCT07091695 · COMPLETED
Trial details
- NCT number
- NCT07091695
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2025-05-11
- Primary completion
- 2025-11-06
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.